GLP-1 Therapies Emerge as Key Tools in CKD Prevention—But Long-Term Success Hinges on Patient Engagement
- January 29, 2026
How Shenqi Dihuang Decoction May Target Key Pathways in IgA Nephropathy: New Mechanistic Insights
The Value of Living with Tremendous Challenges
A Cellular Solution to America’s Opioid Crisis: Biotech Advances Alternative to Chronic Pain Management
LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
Comprehensive Cancer Fighter: FDA Fast-Tracks Innovative Breast Cancer Therapy bit.ly/3NB3dri Read now at PatientWorthy.com
#PatientWorthy #BreastCancer #FDAapproval
Cystic fibrosis affects daily life in ways most people never see. Awareness helps bring visibility to those realities, builds understanding, and supports continued research and access to care. The more people know about CF, the stronger the support becomes for those living with it — now and in the future. #cysticfibrosis #CF #RareDisease #PatientWorthy
Shenqi Dihuang, a traditional Chinese medicine historically used to treat kidney ailments, may be an effective treatment for IgA Nephropathy, according to a recent study. Read more here:
patientworthy.com/2026/01/28/how-shenqi-dihuang-decoction-may-target-key-pathways-in-iga-nephropa...
